Douglas S McCorkle Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas S McCorkle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas S McCorkle. Douglas S McCorkle is VP Controller & Asst Treasurer in REGENERON PHARMACEUTICALS INC ($REGN) and VP Controller and Asst Treasur in REGENERON PHARMACEUTICALS INC ($REGN) and VP, Controller and Asst. Treas in REGENERON PHARMACEUTICALS INC ($REGN).
Douglas S McCorkle in REGENERON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas S McCorkle: VP Controller & Asst Treasurer, VP Controller and Asst Treasur, VP, Controller and Asst. Treas
Holdings: 6,866 shares
Current Value: $2,455,900
Latest Transaction: Dec 29 2015
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Douglas S McCorkle in REGENERON PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 3,954 | 205,727 | 0 | |
| Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 552.08 | 3,954 | 2,182,924 | 6,866 | 10.8 K to 6.9 K (-36.54 %) |
| Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 3,954 | 205,727 | 10,820 | 6.9 K to 10.8 K (+57.59 %) |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 555.67 | 3,800 | 2,111,546 | 3,800 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 1,921 | 99,950 | 6,866 | 4.9 K to 6.9 K (+38.85 %) |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 270.43 | 4,800 | 1,298,064 | 15,000 | |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 270.43 | 200 | 54,086 | 19,800 | |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 585.51 | 4,800 | 2,810,448 | 4,945 | 9.7 K to 4.9 K (-49.26 %) |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 270.43 | 4,800 | 1,298,064 | 9,745 | 4.9 K to 9.7 K (+97.07 %) |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 586.00 | 200 | 117,200 | 4,945 | 5.1 K to 4.9 K (-3.89 %) |
| Aug 05 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 270.43 | 200 | 54,086 | 5,145 | 4.9 K to 5.1 K (+4.04 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 179.13 | 13,000 | 2,328,690 | 13,000 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 464 | 14,212 | 0 | |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 464 | 14,212 | 4,945 | 4.5 K to 4.9 K (+10.35 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 515.60 | 13,000 | 6,702,800 | 4,481 | 17.5 K to 4.5 K (-74.37 %) |
| May 26 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 179.13 | 13,000 | 2,328,690 | 17,481 | 4.5 K to 17.5 K (+290.11 %) |
| Feb 27 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 416.24 | 3,000 | 1,248,720 | 4,481 | 7.5 K to 4.5 K (-40.10 %) |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 2,800 | 85,764 | 464 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 2,800 | 85,764 | 7,481 | 4.7 K to 7.5 K (+59.82 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 399.66 | 17,000 | 6,794,220 | 17,000 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 5,875 | 305,676 | 3,954 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 943 | 28,884 | 0 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 1,368 | 41,902 | 943 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,311 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,411 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 100 | 3,063 | 2,511 | |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.00 | 5,875 | 2,408,750 | 4,681 | 10.6 K to 4.7 K (-55.66 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 5,875 | 305,676 | 10,556 | 4.7 K to 10.6 K (+125.51 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.00 | 943 | 386,630 | 4,681 | 5.6 K to 4.7 K (-16.77 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 943 | 28,884 | 5,624 | 4.7 K to 5.6 K (+20.15 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 410.16 | 1,368 | 561,099 | 4,681 | 6 K to 4.7 K (-22.62 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 1,368 | 41,902 | 6,049 | 4.7 K to 6 K (+29.22 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 411.06 | 100 | 41,106 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 412.05 | 100 | 41,205 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 417.34 | 100 | 41,734 | 4,681 | 4.8 K to 4.7 K (-2.09 %) |
| Dec 17 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 100 | 3,063 | 4,781 | 4.7 K to 4.8 K (+2.14 %) |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 56 | 1,715 | 3,264 | |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.25 | 1,625 | 34,531 | 0 | |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.25 | 1,625 | 34,531 | 4,681 | 3.1 K to 4.7 K (+53.17 %) |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 56 | 1,715 | 3,056 | 3 K to 3.1 K (+1.87 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 5,875 | 305,676 | 9,829 | |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 353.00 | 5,875 | 2,073,875 | 3,000 | 8.9 K to 3 K (-66.20 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 5,875 | 305,676 | 8,875 | 3 K to 8.9 K (+195.83 %) |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.25 | 3,000 | 63,750 | 1,625 | |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.25 | 3,000 | 63,750 | 3,000 | 0 to 3 K |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 5,819 | 178,236 | 2,611 | |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 325.00 | 5,819 | 1,891,175 | 0 | 5.8 K to 0 (-100.00 %) |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 5,819 | 178,236 | 5,819 | 0 to 5.8 K |
| Jan 14 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 290.00 | 4,000 | 1,160,000 | 0 | 4 K to 0 (-100.00 %) |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 270.43 | 20,000 | 5,408,600 | 20,000 | |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 52.03 | 5,875 | 305,676 | 15,704 | |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 247.21 | 593 | 146,596 | 4,000 | 4.6 K to 4 K (-12.91 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 246.43 | 600 | 147,858 | 4,593 | 5.2 K to 4.6 K (-11.55 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 245.95 | 100 | 24,595 | 5,193 | 5.3 K to 5.2 K (-1.89 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 244.30 | 100 | 24,430 | 5,293 | 5.4 K to 5.3 K (-1.85 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 243.09 | 100 | 24,309 | 5,393 | 5.5 K to 5.4 K (-1.82 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 242.38 | 100 | 24,238 | 5,493 | 5.6 K to 5.5 K (-1.79 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 241.45 | 620 | 149,699 | 5,593 | 6.2 K to 5.6 K (-9.98 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Payment of Exercise | F | 233.53 | 2,354 | 549,730 | 6,213 | 8.6 K to 6.2 K (-27.48 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Payment of Exercise | F | 233.53 | 1,308 | 305,457 | 8,567 | 9.9 K to 8.6 K (-13.25 %) |
| May 03 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 52.03 | 5,875 | 305,676 | 9,875 | 4 K to 9.9 K (+146.88 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 5,875 | 179,951 | 8,430 | |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 214.10 | 300 | 64,230 | 4,000 | 4.3 K to 4 K (-6.98 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 213.12 | 298 | 63,510 | 4,300 | 4.6 K to 4.3 K (-6.48 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 212.54 | 318 | 67,588 | 4,598 | 4.9 K to 4.6 K (-6.47 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 211.47 | 731 | 154,585 | 4,916 | 5.6 K to 4.9 K (-12.94 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 210.65 | 600 | 126,390 | 5,647 | 6.2 K to 5.6 K (-9.60 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 209.48 | 482 | 100,969 | 6,247 | 6.7 K to 6.2 K (-7.16 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 208.25 | 200 | 41,650 | 6,729 | 6.9 K to 6.7 K (-2.89 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 207.32 | 100 | 20,732 | 6,929 | 7 K to 6.9 K (-1.42 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 205.82 | 100 | 20,582 | 7,029 | 7.1 K to 7 K (-1.40 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 204.57 | 1,867 | 381,932 | 7,129 | 9 K to 7.1 K (-20.75 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 204.57 | 879 | 179,817 | 8,996 | 9.9 K to 9 K (-8.90 %) |
| Apr 16 2013 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 5,875 | 179,951 | 9,875 | 4 K to 9.9 K (+146.88 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 21.25 | 3,873 | 82,301 | 0 | |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 21.25 | 200 | 4,250 | 4,625 | |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 21.25 | 100 | 2,125 | 4,825 | |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 21.25 | 300 | 6,375 | 4,925 | |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 21.25 | 152 | 3,230 | 5,225 | |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 180.75 | 100 | 18,075 | 4,000 | 4.1 K to 4 K (-2.44 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 177.83 | 100 | 17,783 | 4,100 | 4.2 K to 4.1 K (-2.38 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 176.46 | 100 | 17,646 | 4,200 | 4.3 K to 4.2 K (-2.33 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 175.53 | 541 | 94,962 | 4,300 | 4.8 K to 4.3 K (-11.18 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 174.52 | 1,000 | 174,520 | 4,841 | 5.8 K to 4.8 K (-17.12 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 177.46 | 200 | 35,492 | 5,841 | 6 K to 5.8 K (-3.31 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 21.25 | 200 | 4,250 | 6,041 | 5.8 K to 6 K (+3.42 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 178.46 | 100 | 17,846 | 5,841 | 5.9 K to 5.8 K (-1.68 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 21.25 | 100 | 2,125 | 5,941 | 5.8 K to 5.9 K (+1.71 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 179.51 | 300 | 53,853 | 5,841 | 6.1 K to 5.8 K (-4.89 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 21.25 | 300 | 6,375 | 6,141 | 5.8 K to 6.1 K (+5.14 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 180.36 | 152 | 27,415 | 5,841 | 6 K to 5.8 K (-2.54 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 21.25 | 152 | 3,230 | 5,993 | 5.8 K to 6 K (+2.60 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Payment of Exercise | F | 178.62 | 1,572 | 280,791 | 5,841 | 7.4 K to 5.8 K (-21.21 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Payment of Exercise | F | 178.62 | 460 | 82,165 | 7,413 | 7.9 K to 7.4 K (-5.84 %) |
| Dec 20 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 21.25 | 3,873 | 82,301 | 7,873 | 4 K to 7.9 K (+96.83 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | A | 179.13 | 26,000 | 4,657,380 | 26,000 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 16.80 | 200 | 3,360 | 0 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 16.80 | 800 | 13,440 | 200 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Option Exercise | M | 16.80 | 4,000 | 67,200 | 1,000 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 178.19 | 200 | 35,638 | 4,000 | 4.2 K to 4 K (-4.76 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 16.80 | 200 | 3,360 | 4,200 | 4 K to 4.2 K (+5.00 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | S | 179.45 | 800 | 143,560 | 4,000 | 4.8 K to 4 K (-16.67 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 16.80 | 800 | 13,440 | 4,800 | 4 K to 4.8 K (+20.00 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Buy | M | 16.80 | 4,000 | 67,200 | 4,000 | 0 to 4 K |
| Aug 28 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller & Ass ... | Sell | I | 145.23 | 256 | 37,179 | 4,008 | 4.3 K to 4 K (-6.00 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 5,875 | 179,951 | 14,305 | |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.25 | 9,250 | 196,563 | 3,873 | |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 146.07 | 200 | 29,214 | 0 | 200 to 0 (-100.00 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 145.22 | 2,149 | 312,078 | 200 | 2.3 K to 200 (-91.49 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 144.67 | 4,178 | 604,431 | 2,349 | 6.5 K to 2.3 K (-64.01 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 142.71 | 200 | 28,542 | 6,527 | 6.7 K to 6.5 K (-2.97 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 141.85 | 3,623 | 513,923 | 6,727 | 10.4 K to 6.7 K (-35.00 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 141.85 | 1,385 | 196,462 | 10,350 | 11.7 K to 10.4 K (-11.80 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.25 | 9,250 | 196,563 | 11,735 | 2.5 K to 11.7 K (+372.23 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 141.85 | 2,122 | 301,006 | 2,485 | 4.6 K to 2.5 K (-46.06 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 141.85 | 1,268 | 179,866 | 4,607 | 5.9 K to 4.6 K (-21.58 %) |
| Aug 27 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 5,875 | 179,951 | 5,875 | 0 to 5.9 K |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.92 | 15,438 | 338,401 | 0 | |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 16.80 | 15,000 | 252,000 | 0 | |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.92 | 4,062 | 89,039 | 0 | |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.92 | 500 | 10,960 | 4,062 | |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 107.50 | 5,353 | 575,448 | 0 | 5.4 K to 0 (-100.00 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 111.08 | 9,097 | 1,010,495 | 5,353 | 14.5 K to 5.4 K (-62.96 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 111.01 | 5,864 | 650,963 | 14,450 | 20.3 K to 14.5 K (-28.87 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 111.01 | 2,269 | 251,882 | 20,314 | 22.6 K to 20.3 K (-10.05 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 16.80 | 15,000 | 252,000 | 22,583 | 7.6 K to 22.6 K (+197.81 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 111.01 | 4,807 | 533,625 | 7,583 | 12.4 K to 7.6 K (-38.80 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Payment of Exercise | F | 111.01 | 3,048 | 338,358 | 12,390 | 15.4 K to 12.4 K (-19.74 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.92 | 15,438 | 338,401 | 15,438 | 0 to 15.4 K |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 109.01 | 4,062 | 442,799 | 0 | 4.1 K to 0 (-100.00 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.92 | 4,062 | 89,039 | 4,062 | 0 to 4.1 K |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 110.50 | 500 | 55,250 | 0 | 500 to 0 (-100.00 %) |
| Feb 16 2012 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.92 | 500 | 10,960 | 500 | 0 to 500 |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 52.03 | 21,579 | 1,122,755 | 21,579 | |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 52.03 | 1,921 | 99,950 | 1,921 | |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 20.32 | 6,850 | 139,192 | 0 | |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 20.32 | 3,750 | 76,200 | 0 | |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 40.02 | 6,850 | 274,137 | 0 | 6.9 K to 0 (-100.00 %) |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 20.32 | 6,850 | 139,192 | 6,850 | 0 to 6.9 K |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 40.02 | 3,750 | 150,075 | 0 | 3.8 K to 0 (-100.00 %) |
| Mar 22 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 20.32 | 3,750 | 76,200 | 3,750 | 0 to 3.8 K |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 20.32 | 1,988 | 40,396 | 6,850 | |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 20.32 | 7,412 | 150,612 | 3,750 | |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 40.00 | 1,988 | 79,520 | 0 | 2 K to 0 (-100.00 %) |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 20.32 | 1,988 | 40,396 | 1,988 | 0 to 2 K |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 40.00 | 7,412 | 296,480 | 0 | 7.4 K to 0 (-100.00 %) |
| Mar 11 2011 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 20.32 | 7,412 | 150,612 | 7,412 | 0 to 7.4 K |